These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9634757)

  • 1. An allosteric hammerhead ribozyme.
    Porta H; Lizardi PM
    Biotechnology (N Y); 1995 Feb; 13(2):161-4. PubMed ID: 9634757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ribozyme cleavage activity by oligonucleotides.
    Komatsu Y; Ohtsuka E
    Methods Mol Biol; 2004; 252():165-77. PubMed ID: 15017048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of allosteric ribozymes.
    Tang J; Breaker RR
    Chem Biol; 1997 Jun; 4(6):453-9. PubMed ID: 9224568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons.
    Robertson MP; Ellington AD
    Nat Biotechnol; 1999 Jan; 17(1):62-6. PubMed ID: 9920271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric hammerhead ribozyme TRAPs.
    Burke DH; Ozerova ND; Nilsen-Hamilton M
    Biochemistry; 2002 May; 41(21):6588-94. PubMed ID: 12022862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection of hairpin ribozymes activated with short oligonucleotides.
    Komatsu Y; Nobuoka K; Karino-Abe N; Matsuda A; Ohtsuka E
    Biochemistry; 2002 Jul; 41(29):9090-8. PubMed ID: 12119023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural flexibility and the thermodynamics of helix exchange constrain attenuation and allosteric activation of hammerhead ribozyme TRAPs.
    Saksmerprome V; Burke DH
    Biochemistry; 2003 Dec; 42(47):13879-86. PubMed ID: 14636055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altering molecular recognition of RNA aptamers by allosteric selection.
    Soukup GA; Emilsson GA; Breaker RR
    J Mol Biol; 2000 May; 298(4):623-32. PubMed ID: 10788325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
    J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring post-translational modification of proteins with allosteric ribozymes.
    Vaish NK; Dong F; Andrews L; Schweppe RE; Ahn NG; Blatt L; Seiwert SD
    Nat Biotechnol; 2002 Aug; 20(8):810-5. PubMed ID: 12118241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oligodeoxyribonucleotide that supports catalytic activity in the hammerhead ribozyme domain.
    Chartrand P; Harvey SC; Ferbeyre G; Usman N; Cedergren R
    Nucleic Acids Res; 1995 Oct; 23(20):4092-6. PubMed ID: 7479070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions.
    Long DM; Uhlenbeck OC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6977-81. PubMed ID: 7518924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
    O'Rourke SM; Estell W; Scott WG
    J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein.
    Wang DY; Sen D
    Comb Chem High Throughput Screen; 2002 Jun; 5(4):301-12. PubMed ID: 12052181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.